REVIVA PHARMACEUTICALS HOLDINGS, INC.
Clinical-stage biopharma developing therapeutics for CNS, respiratory & metabolic diseases.
RVPH | US
Overview
Corporate Details
- ISIN(s):
- VGG8708A1167 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 10080 N WOLFE ROAD, 95014 CUPERTINO
- Website:
- https://revivapharma.com/
Description
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company that discovers and develops next-generation therapeutics for diseases with significant unmet medical needs. The company's primary focus is on central nervous system (CNS), respiratory, and metabolic diseases. Its lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms in Alzheimer's disease, Parkinson's disease psychosis, and attention deficit hyperactivity disorder (ADHD). Reviva utilizes a chemical genomics-driven technology platform to develop medicines with the goal of achieving better safety and efficacy profiles for improved patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all REVIVA PHARMACEUTICALS HOLDINGS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REVIVA PHARMACEUTICALS HOLDINGS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REVIVA PHARMACEUTICALS HOLDINGS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||